CRYO-CELL INTERNATIONAL, INC. Line of Credit Facility, Maximum Amount Outstanding During Period
CRYO-CELL INTERNATIONAL, INC. (CCEL) had Line of Credit Facility, Maximum Amount Outstanding During Period of $150.00 thousand as of 2020-12-01, per its 10-Q filed 2022-10-18.
Discontinued › Notes › Debt
us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod · last filed 2022-10-18
- 2020-12-01: Line of Credit Facility, Maximum Amount Outstanding During Period $150.00K.
- 2020-06-30: Line of Credit Facility, Maximum Amount Outstanding During Period $150.00K.
| Period end | Line of Credit Facility, Maximum Amount Outstanding During Period |
|---|---|
| 2020-12-01 | $150.00K 10-Q · filed 2022-10-18 |
| 2020-06-30 | $150.00K 10-Q · filed 2022-10-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |